Rankings
▼
Calendar
SLNO (Soleno Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
SLNO
Soleno Therapeutics, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$190M
Net Income (TTM)
$21M
EPS (TTM)
$0.23
Free Cash Flow (TTM)
$47M
Gross Margin
98.6%
Op. Margin
5.4%
Net Margin
11.0%
FCF Margin
24.6%
P/S Ratio (TTM)
11.2x
P/E Ratio (TTM)
102.4x
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$8M
Q2 23
$0
$0
-$9M
Q3 23
$0
$0
-$10M
Q4 23
$0
$0
-$14M
Q1 24
$0
$0
-$23M
Q2 24
$0
-$494K
-$23M
Q3 24
$0
$0
-$80M
Q4 24
$0
$0
-$59M
Q1 25
$0
$0
-$46M
Q2 25
$33M
$32M
-$7M
Q3 25
$66M
$65M
$22M
Q4 25
$92M
$91M
$40M
marketcaparena.com
Revenue Breakdown
SLNO
Soleno Therapeutics, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
—
—
Q2 25
65.5x
—
Q3 25
21.7x
—
Q4 25
11.2x
102.4x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$7M
-$7M
Q2 23
-$6M
-$6M
Q3 23
-$6M
-$6M
Q4 23
-$6M
-$6M
Q1 24
-$13M
-$13M
Q2 24
-$18M
-$18M
Q3 24
-$15M
-$15M
Q4 24
-$24M
-$24M
Q1 25
-$33M
-$33M
Q2 25
-$13M
-$13M
Q3 25
$44M
$44M
Q4 25
$49M
$49M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$11K
Q2 24
$8K
Q3 24
$191K
Q4 24
$8K
Q1 25
$5K
Q2 25
$9K
Q3 25
$1K
Q4 25
$58K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+46.7%
Q2 23
—
+27.2%
Q3 23
—
+66.5%
Q4 23
—
+148.0%
Q1 24
—
+177.2%
Q2 24
—
+169.4%
Q3 24
—
+672.6%
Q4 24
—
+325.0%
Q1 25
—
+94.9%
Q2 25
—
+68.7%
Q3 25
—
-45.3%
Q4 25
—
-13.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$631K
—
Q2 23
$1M
—
Q3 23
$2M
—
Q4 23
$2M
—
Q1 24
$6M
—
Q2 24
$7M
—
Q3 24
$57M
—
Q4 24
$30M
—
Q1 25
$15M
—
Q2 25
$10M
29.7%
Q3 25
$0
0.0%
Q4 25
$11M
12.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$5M
$3M
—
Q2 23
$5M
$3M
—
Q3 23
$6M
$3M
—
Q4 23
$9M
$4M
—
Q1 24
$15M
$8M
—
Q2 24
$12M
$11M
—
Q3 24
$30M
$49M
—
Q4 24
$21M
$37M
—
Q1 25
$14M
$29M
—
Q2 25
$9M
$28M
—
Q3 25
$8M
—
$34M
Q4 25
$10M
—
$41M
marketcaparena.com
Revenue Segments
Product
Quarter
Product
Q2 25
$33M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$8M
$0
$8M
Q2 23
$19M
$0
$19M
Q3 23
$52M
$0
$52M
Q4 23
$170M
$0
$170M
Q1 24
$43M
$107M
$150M
Q2 24
$57M
$209M
$266M
Q3 24
$48M
$208M
$257M
Q4 24
$88M
$204M
$291M
Q1 25
$81M
$209M
$290M
Q2 25
$76M
$210M
$287M
Q3 25
$247M
$252M
$499M
Q4 25
$70M
$235M
$305M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
9M
+0.1%
Q2 23
10M
+10.3%
Q3 23
11M
+9.7%
Q4 23
26M
+130.4%
Q1 24
36M
+37.4%
Q2 24
39M
+6.7%
Q3 24
42M
+8.4%
Q4 24
44M
+4.9%
Q1 25
46M
+5.1%
Q2 25
50M
+9.3%
Q3 25
55M
+8.8%
Q4 25
54M
-1.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
12
FY 15
$13K
29
FY 16
$56K
26
FY 17
-$129M
12
FY 18
$0
9
FY 19
$0
12
FY 20
$0
17
FY 21
$0
20
FY 22
$0
25
FY 23
$0
33
FY 24
$0
92
FY 25
$476
400K
marketcaparena.com